{"id":10928,"date":"2018-02-20T08:00:09","date_gmt":"2018-02-20T08:00:09","guid":{"rendered":"http:\/\/www.viamedic.com\/blog\/?p=4688"},"modified":"2018-12-09T18:00:59","modified_gmt":"2018-12-09T18:00:59","slug":"when-will-customers-in-the-us-get-real-price-relief-with-viagra","status":"publish","type":"post","link":"https:\/\/www.edrugstore.com\/blog\/erectile-dysfunction\/viagra\/when-will-customers-in-the-us-get-real-price-relief-with-viagra\/","title":{"rendered":"When Will Customers in the US Get Real Price Relief with Viagra?"},"content":{"rendered":"

W<\/span>ith the April 2020 expiration of Pfizer’s U.S. patent on Viagra, prices for the drug are likely to soften further. That expiration should open the door to increased generic competition for the iconic little blue pill.<\/em><\/strong><\/p>\n

It\u2019s coming. When Pfizer\u2019s patent on Viagra expires in April 2020, U.S. customers should be able to save big on the male impotence drug.\u00a0That\u2019s because other manufacturers are certain to rush to market with a number of less expensive generic alternatives.<\/p>\n

This could signal the start of a global price competition with consumers as the real beneficiaries.\u00a0But did you know there are two generic versions of Viagra that are already on the market?<\/p>\n

An Alternative to Viagra?<\/h3>\n

Teva Pharmeceuticals USA Inc.<\/a> reached a deal with Pfizer in 2016 to offer the first generic version of Viagra. That generic, marketed simply as sildenafil citrate, was released in early December of 2017. Almost simultaneously, Greenstone LLC, a wholly owned subsidiary of Pfizer, released its generic formulation of Viagra.<\/p>\n

Both companies are hoping to capture at least a portion of the U.S. demand for Viagra from consumers who would prefer to spend a little bit less. With Pfizer\u2019s patent protecting it from additional generic competition expiring in the next couple of years, other companies, are sure to offer alternatives.<\/p>\n

This is not the first time this has happened to Pfizer; once it lost its patent for Lipitor, the world\u2019s best-selling drug for high cholesterol, lower-priced generics ended up costing Pfizer about $4 billion \u2013 and counting.<\/p>\n

The American Journal of Medicine<\/a>\u00a0<\/em>reports that more than 18 million men suffer from male impotence. Therefore, the real beneficiary of all this medication wrangling is the American consumer.<\/p>\n

Ordering your ED medications from longtime online facilitator eDrugstore.com can often save you time and money. Based in Tempe, Arizona, eDrugstore offers a full range of ED drugs, including both brand-name and generic products. To learn more, visit its Erectile Dysfunction page.<\/p>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

With the April 2020 expiration of Pfizer’s U.S. patent on Viagra, prices for the drug are likely to soften further. That expiration should open the door to increased generic competition for the iconic little blue pill. It\u2019s coming. When Pfizer\u2019s patent on Viagra expires in April 2020, U.S. customers should be able to save big […]<\/p>\n","protected":false},"author":1,"featured_media":25401,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_autoblog_aioseo_focus_keyphrase":"","_autoblog_aioseo_title":"","_autoblog_aioseo_description":"","footnotes":""},"categories":[17],"tags":[184],"class_list":["post-10928","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-viagra","tag-viagra"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t